Oncternal Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1k | 2.0k | 0.54 |
| 2023-09-30 | $4.1k | 14k | 0.30 |
| 2023-06-30 | $3.5k | 10k | 0.35 |
| 2023-03-31 | $3.2k | 4.1k | 0.79 |
| 2022-12-31 | $4.8k | 4.8k | 1.00 |
| 2022-09-30 | $17k | 17k | 1.00 |
| 2022-06-30 | $184k | 166k | 1.11 |
| 2022-03-31 | $17k | 11k | 1.50 |
| 2021-12-31 | $0 | 25k | 0.00 |
| 2021-09-30 | $692k | 166k | 4.17 |
| 2021-06-30 | $677k | 142k | 4.75 |
| 2021-03-31 | $27k | 3.3k | 8.21 |
| 2020-09-30 | $7.0k | 3.9k | 1.81 |
| 2020-03-31 | $0 | 100 | 0.00 |
| 2019-12-31 | $0 | 412 | 0.00 |
| 2019-09-30 | $8.5k | 1.6k | 5.20 |
| 2019-06-30 | $21k | 1.8k | 11.36 |